Friday, November 20, 2026
Biotech

Sanofi Drug Shortage Leaves Rare Disease Patients Waiting

A supply shortage of a key Sanofi medicine leaves Pompe disease patients waiting for their next dose.

Families who live with rare diseases rely on regular medicine to stay strong. Today, many people with Pompe disease face long delays for care. A key drug from maker Sanofi remains in short supply.

Pompe disease weakens the body's muscles over time. The treatment helps keep muscles working. Missing a dose creates real fear for patients who need steady care to walk and breathe. Sanofi is working to fix the production delays and ship more doses soon.

Drug shortages remind investors how fragile medical supply chains can be. When one factory slows down, people feel the impact right away. Watch for updates from health officials as supply returns to normal levels.

Source: CNBC

#Biotech#Sanofi#Healthcare#Pharmaceuticals

More from Biotech